Skip to content

Clinical trials

Phase 2 Lymphoma, B-Cell, Marginal Zone trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 2 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20111
20131
20171
20181
20193
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Christian Buske2
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1
Gilead Sciences1
Incyte Corporation1
MEI Pharma, Inc.1
Pharmacyclics LLC.1
Regeneron Pharmaceuticals1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular6
Lymphoma, Non-Hodgkin5
Neoplasms4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Waldenstrom Macroglobulinemia3
Blast Crisis2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.